Among U.S. veterans, VE was 86 percent for Moderna and 75 percent for PfizerBioNTech vaccines at ≥120 days after the second dose
Second study shows reduction in rate of death due to COVID-19 with booster dose of BNT162b2
Please login or register first to view this content.
Login Register